Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.

Zhang Y, Wang X, Zhang W, Gong S.

Tumour Biol. 2013 Apr;34(2):973-82. doi: 10.1007/s13277-012-0633-7. Epub 2012 Dec 27.

PMID:
23269608
2.
3.

XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.

Dai QS, Hua RX, Zeng RF, Long JT, Peng ZW.

Tumour Biol. 2014 Jan;35(1):447-53. doi: 10.1007/s13277-013-1062-y. Epub 2013 Aug 6.

PMID:
23918308
4.

XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a meta-analysis.

Peng Q, Lao X, Tang W, Chen Z, Li R, Qin X, Li S.

Diagn Pathol. 2014 Jun 19;9:120. doi: 10.1186/1746-1596-9-120.

5.

Quantitative assessment of the association between XPC Lys939Gln polymorphism and cutaneous melanoma risk.

Zhou L, Lu Y, Yang G, Wu J.

Tumour Biol. 2014 Feb;35(2):1427-32. doi: 10.1007/s13277-013-1196-y. Epub 2013 Nov 26.

PMID:
24277375
6.

Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case-control studies.

Wang Y, Li Z, Liu N, Zhang G.

Tumour Biol. 2014 Apr;35(4):3155-65. doi: 10.1007/s13277-013-1412-9. Epub 2013 Nov 22.

PMID:
24264314
7.

Poly (AT) deletion/insertion polymorphism of the XPC gene contributes to urinary system cancer susceptibility: a meta-analysis.

Dai QS, Hua RX, Zhang R, Huang YS, Hua ZM, Yun CT, Zeng RF, Long JT.

Gene. 2013 Oct 10;528(2):335-42. doi: 10.1016/j.gene.2013.06.092. Epub 2013 Jul 24.

PMID:
23892089
8.

Association of XPC polymorphisms and lung cancer risk: a meta-analysis.

Jin B, Dong Y, Zhang X, Wang H, Han B.

PLoS One. 2014 Apr 15;9(4):e93937. doi: 10.1371/journal.pone.0093937. eCollection 2014.

9.

Associations between polymorphisms of the XPC gene and lung cancer susceptibility: a meta-analysis.

Zhu ML, Hua RX, Zheng L.

Tumour Biol. 2014 Apr;35(4):2931-9. doi: 10.1007/s13277-013-1377-8. Epub 2013 Dec 28.

PMID:
24375193
10.
11.

XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy.

Gangwar R, Mandhani A, Mittal RD.

J Cancer Res Clin Oncol. 2010 May;136(5):779-86. doi: 10.1007/s00432-009-0717-y. Epub 2009 Nov 19.

PMID:
19924443
12.

XPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.

Liu C, Yin Q, Ying M, Lin J, Li L, Jiao G, Wang M, Wang Y.

Mol Biol Rep. 2014 Feb;41(2):1171-8. doi: 10.1007/s11033-013-2964-x. Epub 2014 Jan 3.

PMID:
24385304
13.

Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.

He J, Shi TY, Zhu ML, Wang MY, Li QX, Wei QY.

Int J Cancer. 2013 Oct 15;133(8):1765-75. doi: 10.1002/ijc.28089. Epub 2013 Mar 8.

14.
15.

Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis.

Peng Q, Chen Z, Lu Y, Lao X, Mo C, Li R, Qin X, Li S.

Diagn Pathol. 2014 May 23;9:96. doi: 10.1186/1746-1596-9-96. Review.

16.

Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.

Zhu Y, Lai M, Yang H, Lin J, Huang M, Grossman HB, Dinney CP, Wu X.

Carcinogenesis. 2007 Mar;28(3):698-703. Epub 2006 Oct 19.

PMID:
17052994
17.

Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis.

Zhang Y, Li Z, Zhong Q, Zhou W, Chen X, Chen X, Fang J, Huang Z.

Tumour Biol. 2014 Apr;35(4):3917-31. doi: 10.1007/s13277-013-1520-6. Epub 2013 Dec 13.

PMID:
24338715
18.

Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk.

Liu Y, Wang H, Lin T, Wei Q, Zhi Y, Yuan F, Song B, Yang J, Chen Z.

Oncol Rep. 2012 Jul;28(1):337-45. doi: 10.3892/or.2012.1759. Epub 2012 Apr 9.

PMID:
22505326
19.

A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility.

Liu C, Yin Q, Hu J, Li L, Zhang Y, Wang Y.

Tumour Biol. 2013 Apr;34(2):1205-13. doi: 10.1007/s13277-013-0663-9. Epub 2013 Feb 6.

PMID:
23381646
20.

Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.

Zheng W, Cong XF, Cai WH, Yang S, Mao C, Zou HW.

Breast Cancer Res Treat. 2011 Aug;128(3):811-5. doi: 10.1007/s10549-011-1369-6. Epub 2011 Feb 12.

PMID:
21318603

Supplemental Content

Support Center